Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
AAREYDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aarey Drugs & Pharmaceuticals has submitted to the exchanges a quarterly certificate from its Registrar and Share Transfer Agent, MUFG Intime India Private Limited. The certificate confirms that share certificates received from depository participants for dematerialisation during the quarter ended 31st March 2026 were properly processed, accepted or rejected, and listed on the stock exchanges. It also confirms that physical certificates were mutilated and cancelled after verification, and the names of depositories have been substituted as registered owners in the company's register of members within the timelines prescribed by SEBI. The filing was signed by Director Nimit Ghatalia (DIN: 07069841).
This is a routine, mandatory quarterly compliance filing under SEBI's depository regulations and carries no material impact on the business, operations, or stock price. It simply certifies that share dematerialisation activities for the January–March 2026 quarter were handled correctly.